Author: Anna Williams

This article was originally published in the Breakthroughs Newsletter. Find more stories like this, as well as the new Breakthroughs Podcast, on the Breakthroughs homepage. At the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, the collaborative team of investigators dedicated to confronting cancer has never been stronger. In August, the Lurie Cancer Center was awarded the highest rating possible from the National Cancer Institute (NCI) — an overall “exceptional” score — during the renewal of its designation as a Comprehensive Cancer Center. As a Comprehensive Cancer Center, the Lurie Cancer Center not only provides world-class clinical care to patients, but…

Basic Science conducted by investigators at Northwestern’s Les Turner ALS Center is building a foundation for future ALS care.

Lori Post, director of Feinberg’s Buehler Center for Health Policy and Economics, takes a high-level approach to protect worldwide victims of abuse, neglect and exploitation.

Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.

Through innovative transitional care programs,
Northwestern Medicine clinicians help vulnerable
patients achieve healthier lives after leaving the hospital.

Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.

New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.

Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.

Deputy Director Maha Hussain, MD oversees clinical research at the Lurie Cancer Center, but never forgets her primary goal: having an impact on patients.

Northwestern Medicine scientists usher in a new era of genetic research. Learn how our investigators are using CRISPR technology to isolate mutations that cause neurological diseases and to understand how individual genes can damage or protect cells.